‍

Sasha Said holds a dual bachelor’s degree in Business Economics and East Asian History from Brown University (2006). She has expertise in several areas including growth, commercial operations, and capital raising within the healthcare, life sciences, and digital health realms. Most recently, she founded SKS Life Science Consulting (2021), advising companies on strategy, structure, and best practices for fast revenue growth in early commercialization through late-stage growth, including sales, marketing, customer success, product and implementation, and patient engagement. Said provides strategic capital raising support, helps launch products in life sciences, and identifies new markets for growth.

As a member of the Advisory Board, Said brings with her extensive consulting experience identifying new growth opportunities and helping healthcare companies build and scale commercial operations with a specialized focus in digital health for life sciences, primary and specialty clinics, healthcare data, and patient-centric solutions, which are valuable to Radyus.

In her previous role at LetsGetChecked, Said was responsible for growing the enterprise business for the company. She built a team and strategy to bring LGC’s revenue to triple digit millions. She was also pivotal in helping the company fund raise and close an over-subscribed $71M Series C. Prior to LetsGetChecked, Said was a founding member of the Transformation Capital Fund where she sourced and structured deals and provided representation for LTP on various Boards of Directors including Vera Whole Health, Panalgo, Groups Recover Together, LetsGetChecked, and, notably, Health Catalyst (NASDAQ: HCAT), where she helped launch the company's life sciences division. Companies she has worked with have collectively raised over $1B during her involvement.

She currently advises several companies on their sales, marketing, and growth strategy. During the Covid-19 pandemic, she advised Truepill on their life sciences commercial strategy, product, and market launch, Free Market Health on their successful $13.5M Series A capital raise, and CIC Health on the growth of their Covid-19 vaccine and pooled testing businesses. Sasha Said has a bachelor’s degree in Business Economics and East Asian History from Brown University.

Said has contributed to the launch of 5 first time funds over the course of her career. Prior to LTP, she built the corporate venture capital group at Waypoint Capital, a $15B family office and helped launch Gurnet Point Capital, a $2B life science fund. Said has also previously covered an opportunity set of 250+ global companies at Water Asset Management, a global hedge fund in NYC. She was co-Founder and Chairman of The Pharma Digital Health Roundtable, which convened senior level life science leaders to discuss the adoption of innovative digital solutions (200+ execs) in biopharma, and Founder of B7, a network of over 100 women in VC and business development in Boston. Said’s goal is to support companies that have or will have a large-scale impact on human health.